IRCT201009112181N5已完成未知
The role of ranitidine in the prevention of olanzapine induced weight gain
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit（—）
- 性别
- All
入选标准
- •Taking olanzapine for thought disorder, Hospitalization for over 16 weeks, signing informed written consent
- •Exclusion criteria: The physical co-morbidity, Simultaneous taking of drugs with weight gain side effect, Special diets
排除标准
- 未提供
研究者
相似试验
已完成
不适用
Effectiveness of ranitidine in weight gain caused by olanzapine in patients with schizophreniaCTRI/2014/07/004740Central Institute of Psychiatry75
进行中（未招募）
1 期
The use of amantadine in the prevention of progression and treatment of COVID-19 symptoms in patients infected with the SARS-CoV-2 virusEUCTR2021-001144-98-PLSamodzielny Publiczny Szpital Kliniczny Nr 4 w Lublinie200
已完成
不适用
Feasibility of Olanzapine for the prevention of chemotherapy-induced nausea and vomiting in patients receiving 5-day chemotherapy rejimensPatients receiving multiple chemotherapy including highly or moderate emetogenic agentsJPRN-UMIN000015386ational cancer center hospital18
进行中（未招募）
1 期
A study that investigates whether ranitidine has a added value in the prevention of paclitaxel-induced allergic reactionsEUCTR2017-003535-11-NLErasmus MC554
尚未招募
不适用
The comparison of the efficacy of two combined therapeutic regimens in the treatment of gastroesophageal reflux disease in term neonatesGastroesophageal reflux in mature neonate.Other specified perinatal digestive system disordersIRCT20160827029535N3Investigator60